Composition: Each 100 ml contains: Iron (Iron III - hydroxide dextran complex): 20 g Cyanocobalamin (vitamin B12): 10 mg Solvent qs: 100 ml Indications Treatment and prevent for anemia due to iron deficiency in piglets, calves, goats, and sheep
Thymosin 4 induces angiogenesis in critical limb ischemia mice via regulating Notch/NFB pathway
The TGA reports a number of adverse events and other concerns received for unapproved peptide products, which include: severe allergic reactions, requiring doses of adrenaline and hospitalisation systemic inflammatory response syndrome (SIRS) (severe inflammation in the body), requiring hospital management generalised hypersensitivity symptoms such as fullbody intense itching, palpitations, pain and sweating wide ranging body side effects, including insomnia, blurred vision, extreme tiredness, flulike illness, joint pain and skin sensitivity musculoskeletal injuries, including plantar fasciitis and Achilles tendinitis, and poor product quality, including unsealed packaging from an online supplier
Higher concentrations (10mg/mL or greater) reduce injection volume but amplify measurement erroreach 0.01mL syringe increment represents 100mcg peptide, introducing 2040% relative error for sub-250mcg doses
